Literature DB >> 19647759

Human anti-snake venom IgG antibodies in a previously bitten snake-handler, but no protection against local envenoming.

Geoffrey K Isbister1, Lambros Halkidis, Margaret A O'Leary, Richard Whitaker, Paul Cullen, Richard Mulcahy, Robert Bonnin, Simon G A Brown.   

Abstract

We report a 60 year old male bitten by snakes from the Acanthophis genus (Death adder) on two occasions who developed high titres of human IgG antibodies to Acanthophis venom detected at the time of the second bite. The patient was bitten by Acanthophis antarcticus (common death adder) on the first occasion, developed non-specific systemic effects and did not receive antivenom. Three months later he was bitten by Acanthophis praelongus (northern death adder) and he developed significant local myotoxicity associated with a moderate rise in the creatine kinase (maximum 4770 U/L). He was given antivenom 55 h after the bite and recovered over several days. Death adder venom was detected in serum at the time of the first bite, but not the second bite. Human IgG antibodies to death adder were detected on the second admission but not the first. However, despite the presence of antibodies to death adder venom and free venom not being detected, the patient still developed significant local myotoxicity. Copyright 2009. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647759     DOI: 10.1016/j.toxicon.2009.07.034

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  5 in total

1.  Antibody responses to natural rattlesnake envenomation and a rattlesnake toxoid vaccine in horses.

Authors:  Lyndi L Gilliam; Robert C Carmichael; Todd C Holbrook; Jennifer M Taylor; Charlotte L Ownby; Dianne McFarlane; Mark E Payton
Journal:  Clin Vaccine Immunol       Date:  2013-03-20

2.  Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16).

Authors:  Christopher I Johnston; Margaret A O'Leary; Simon G A Brown; Bart J Currie; Lambros Halkidis; Richard Whitaker; Benjamin Close; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

Review 3.  Pharmacokinetics of Snake Venom.

Authors:  Suchaya Sanhajariya; Stephen B Duffull; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2018-02-07       Impact factor: 4.546

4.  The Influence of the Different Disposition Characteristics of Snake Toxins on the Pharmacokinetics of Snake Venom.

Authors:  Suchaya Sanhajariya; Geoffrey K Isbister; Stephen B Duffull
Journal:  Toxins (Basel)       Date:  2020-03-16       Impact factor: 4.546

Review 5.  Current Knowledge on Snake Dry Bites.

Authors:  Manuela B Pucca; Cecilie Knudsen; Isadora S Oliveira; Charlotte Rimbault; Felipe A Cerni; Fan Hui Wen; Jacqueline Sachett; Marco A Sartim; Andreas H Laustsen; Wuelton M Monteiro
Journal:  Toxins (Basel)       Date:  2020-10-22       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.